Sandra Cristea
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Immunology top 5%
- Phagocytosis and Immune Regulation
- interferon and immune responses
Papers in
- Oncology 9
- Lung Cancer Research Studies 7
- Cancer Immunotherapy and Biomarkers 1
- Cancer-related Molecular Pathways 1
- Cancer Cells and Metastasis 1
-
- Cancer, Lipids, and Metabolism 1
- Co-authors
- Julien Sage (7 shared papers)Lauren A. Byers (3 shared papers)Triparna Sen (3 shared papers)John Victor Heymach (2 shared papers)Lerong Li (2 shared papers)Bonnie S. Glisson (2 shared papers)Jing Wang (2 shared papers)Don Lynn Gibbons (2 shared papers)
- Journals
- Cancer Research (2 papers)Biotechnology and Bioengineering (1 paper)Journal of Clinical Investigation (1 paper)Clinical Cancer Research (1 paper)Molecular Cell (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Sandra Cristea
12 papers receiving 2.3k citations
Sandra Cristea's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 1.2k
- Immunology 412
- Cancer Research 120
- Molecular Biology 542
- Drug Discovery 2
Countries citing papers authored by Sandra Cristea
This map shows the geographic impact of Sandra Cristea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Cristea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Cristea more than expected).
Fields of papers citing papers by Sandra Cristea
This network shows the impact of papers produced by Sandra Cristea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Cristea. The network helps show where Sandra Cristea may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Cristea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer Hit paper breakdown → | 2019 | 724 |
| 2 | 2017 | 397 | |
| 3 | 2016 | 383 | |
| 4 | 2019 | 237 | |
| 5 | 2017 | 170 | |
| 6 | 2012 | 151 | |
| 7 | 2016 | 71 | |
| 8 | 2020 | 69 | |
| 9 | 2020 | 58 | |
| 10 | 2018 | 47 | |
| 11 | 2016 | 46 | |
| 12 | 2011 | 4 |
About Sandra Cristea
Sandra Cristea is a scholar working on Oncology, Cancer Research, Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 12 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (7 papers), Phagocytosis and Immune Regulation (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), RNA Research and Splicing (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Cancer-related Molecular Pathways (1 paper), Cancer Cells and Metastasis (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Oncology (1.2k citations), Immunology (412 citations), Cancer Research (120 citations), Molecular Biology (542 citations) and Drug Discovery (2 citations). Sandra Cristea has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Julien Sage, Lauren A. Byers, Triparna Sen, John Victor Heymach, Lerong Li, Bonnie S. Glisson, Jing Wang, Don Lynn Gibbons, Thuyen N. Nguyen and Ignacio Ivan Wistuba. Their work appears in journals such as Cancer Research, Biotechnology and Bioengineering, Journal of Clinical Investigation, Clinical Cancer Research and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.